The Standing Committee on Affordable Medicines and Health Products (SCAMHP)

The Government on January 21, 2019 constituted a standing committee headed by NITI Aayog to oversee the drug pricing regime.

  • It is headed by NITI Aayog member (health), and includes chief economic adviser, besides secretary department of health research, director general of health services, vice-chairperson, National List of Essential Medicines (NLEM) and joint secretary department of industrial policy and promotion.
  • SCAMHP committee will be a recommending body to NPPA (National Pharmaceutical Pricing Authority), regarding prices of drugs and health products.
  • It may examine issues suo-moto or on recommendation of department of pharma, NPPA and department of health.

Related Content